A Daver - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

A Daver

Showing results (51-60 of 52) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 52 results.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002

[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.

Cancer|March 19, 2021

Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaElias Jabbour, Koji Sasaki, Nicholas J Short, et al.

Pageof 6

Search research articles

Showing results (51-60 of 52) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 52 results.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002

[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.

Cancer|March 19, 2021

Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaElias Jabbour, Koji Sasaki, Nicholas J Short, et al.

Pageof 6